Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Saved in:
| Title: | Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. |
|---|---|
| Authors: | Chung, C. H.1,2,3, Aulino, J.4, Muldowney, N. J.3, Hatakeyama, H.1, Baumann, J.1, Burkey, B.5, Netterville, J.5, Sinard, R.5, Yarbrough, W. G.2,3,5, Cmelak, A. J.6, Slebos, R. J.2, Shyr, Y.7, Parker, J.8, Gilbert, J.1, Murphy, B. A.1 |
| Source: | Annals of Oncology. Apr2010, Vol. 21 Issue 4, p864-870. 7p. 2 Diagrams, 2 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
